CLINICAL TRIALS


This Is ADAX experience in vulnerable populations:

  • Rheumatology: Juvenile idiopatic arthritis – poliarticular, Juvenile idiopatic arthritis - oligoarticular
  • Endocrinology: Type 1 Diabetes Mellitus (2 studies)
  • Cardiology: Congenital heart disease
  • Hematology: Haemophilia A (2 studies), Haemophilia B
  • Neurology: Alzheimer dementia (3 studies)